clinical trial · NCT03840915
M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)
EMD Serono Research & Development Institute, Inc.·phase2·completed·n = 70
Carcinoma, Non-Small-Cell LungCisplatinCarboplatinPemetrexedNab-paclitaxelGemcitabineDocetaxelM7824Carboplatin
brief summary
The main purpose of the study was to evaluate the safety and tolerability of M7824 in combination with chemotherapy.
started
Apr 2, 2019
primary completion
Jul 29, 2022
completion
Jul 29, 2022
last updated
Aug 21, 2023
official title
A Phase Ib/II, Open-Label Study of M7824 in Combination With Chemotherapy in Participants With Stage IV Non-small Cell Lung Cancer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol